ClinicalTrials.gov
ClinicalTrials.gov Menu

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00513383
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : March 1, 2017
Sponsor:
Collaborators:
Brigham and Women's Hospital
Amgen
Information provided by (Responsible Party):
Lori J. Wirth, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2010
  Actual Study Completion Date : October 2012
Publications:
Wirth, L.J. Phase I Study of Panitumumab, Chemotherapy, and Intensity-modulated Radiotherapy (IMRT) for head and neck cancer (HNC). Abstract-No.6083 2007 ASCO Annual Meeting